PAP IB, a new member of the Reg gene family: cloning, expression, structural properties, and evolution by gene duplication. by Laurine, Emmanuelle et al.
PAP IB, a new member of the Reg gene family: cloning,
expression, structural properties, and evolution by gene
duplication.
Emmanuelle Laurine, Xavier Manival, Claudine Montgelard, Chantal Bideau,
Jean-Louis Berge´-Lefranc, Monique Erard, Jean-Michel Verdier
To cite this version:
Emmanuelle Laurine, Xavier Manival, Claudine Montgelard, Chantal Bideau, Jean-Louis
Berge´-Lefranc, et al.. PAP IB, a new member of the Reg gene family: cloning, expression, struc-
tural properties, and evolution by gene duplication.. BBA - Biochimica et Biophysica Acta,
Elsevier, 2005, 1727 (3), pp.177-87. <10.1016/j.bbaexp.2005.01.011>. <inserm-00143539>
HAL Id: inserm-00143539
http://www.hal.inserm.fr/inserm-00143539
Submitted on 25 Apr 2007
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destine´e au de´poˆt et a` la diffusion de documents
scientifiques de niveau recherche, publie´s ou non,
e´manant des e´tablissements d’enseignement et de
recherche franc¸ais ou e´trangers, des laboratoires
publics ou prive´s.

1PAP IB, a new member of the Reg gene family: cloning, expression,
structural properties, and evolution by gene duplication
Emmanuelle Laurinea1, Xavier Manivalb2, Claudine Montgelardc, Chantal Bideau
d
, Jean-
Louis Bergé-Lefranc
d
, Monique Érarde, Jean-Michel Verdiera3
a INSERM U710, 34095 Montpellier, France; Université Montpellier II, 34095
Montpellier, France; École Pratique des Hautes Études, 34095 Montpellier, France.
b
Institut de Cancérologie et d’Immunologie, 13009 Marseille, France.
c École Pratique des Hautes Études (EPHE)-UMR CNRS 5554, Université
Montpellier II, 34095 Montpellier cedex 05, France.
d
Laboratoire de Biogénotoxicologie EA1784-IFR PMSE 112, Université d’Aix-
Marseille II, 13385 Marseille cedex 05, France.
e Institut de Pharmacologie et de Biologie Structurale (IPBS), 31077 Toulouse cedex
04, France.
1 Current address: The Parkinson’s Institute, Sunnyvale, California 94089.
2
Current address: UMR 7567 CNRS, Faculté des Sciences, 54506 Vandoeuvre-lés-
Nancy, France.
3 Corresponding author. INSERM U710, Université Montpellier II, Place Eugène
Bataillon, CC105, 34095 Montpellier cedex 05, France.
Tel/Fax: (33) 4 67 14 32 91. E-mail: verdier@univ-montp2.fr
Keywords: Reg, phylogeny, PAP IB, homology modeling, charge distribution, structure-
function relationships
2Abstract
Reg proteins are expressed in various organs and are involved in cancers and
neurodegenerative diseases. They display a typical C-type lectin-like domain but possess
additional highly conserved amino acids. By studying human databases and Expressed
Sequence Tags library, we identified a new member called PAP IB. Using probabilistic
approaches, we established a phylogenetic tree of eighteen Reg proteins. The dendogram
showed that they constitute a superfamily composed of three distinct families (FI to FIII) of
paralogues that resulted from duplication. We therefore focused on two proteins, REG Iα and
PAP IB, belonging to the more closely related FI and FII families, respectively. REG Iα and
PAP IB share 50% sequence identity. After cloning PAP IB, however, we found it was
expressed almost only in pancreas, unlike REG Iα, whose expression is ubiquitous. In
addition, by building a model of the structure of PAP IB based on the X-ray structure of
REG Iα, we observed that the two proteins displayed distinctive surface charge distribution,
which may lead to different ligands binding. In spite of their common fold that should result
in closely related functions, REG Iα and PAP IB are a good example of duplication and
divergence, probably with acquisition of new functions, thus participating in the evolution of
the protein repertoire.
31. Introduction
Reg genes belong to a multigene superfamily with the typical C-type lectin-like domain
(CTLD) of C-type lectins. Members of the Reg genes have been described in mammals, and
their expression was studied mainly in relation to pancreatic functions. Analysis of the
Expressed Sequence Tag (EST) collection of sequences and Northern blot experiments in the
literature showed that the expression of Reg genes is not restricted to pancreas; but that it is
also present in various tissues like stomach, colon, testis, ovary, kidney, and brain. As a
consequence, many different functions have been ascribed to Reg proteins. They have been
described as inhibitors of calcium carbonate crystal growth in vitro ([1] and [2]), as growth
factors ([3] and [4]), as mitogens for pancreatic β-cells ([5] and [6]), and as a motoneuron
neurotrophic factor [7]. They have also been implicated in carcinogenesis ([8]; [9] and [10]),
in the improvement of diabetes in murine models ([11] and [12]), and in neurodegenerative
diseases ([13] and [14]).
We thus sought to determine why Reg proteins display such different functions.
Comparative genomics in eukaryotes has revealed that proteins accrete new domains and
concomitantly acquire new functions [15]. “Domain accretion”, inside the same families or
with different families, accounts for the incomparable diversity of eukaryote protein function.
However, this diversity should not be found in Reg proteins. Indeed, because they are small
proteins (around 150 aminoacids), they consist of only one domain, i.e. one evolutionary unit
[16]. As a consequence, more subtle differences in the architectures of Reg proteins should
explain their pleiotropic roles.
The shared chromosomal localization of Reg genes in humans (2p12 [17], [18]) and mice
(6C [19], their tandem order, and their common intron-exon organization [17] suggest they
likely derived by duplication from a common ancestor. In this report, we describe the
4identification of a new member of the Reg family. By leading detailed phylogenetic analyses
of the evolution within this family, and fine structural analysis, we then provide a framework
for further functional research on Reg proteins.
2. Material & Methods
2.1. Construction of the data file
The near completion of the human genome sequencing project ([20] and [21]) allowed us
to derive the quasi-complete set of Reg genes in a vertebrate genome. To obtain the most
exhaustive analysis, we screened all the genomic and structural databases available, i.e. the
non-redundant GenBank/European Molecular Biology Laboratory database, the DNA data
bank of Japan, the human Expressed Sequence Tag library (dbEST), the human genome
project-derived sequences (draft genome, High Throughput Genomic Sequences), the
Swissprot database, the Protein family (Pfam), and the Structural Classification of Proteins
(SCOP). During our work, four successive drafts of the human genome became available. The
data presented in this paper were obtained from the latest version.
2.2. Sequence alignment
Eighteen complete sequences of the Reg superfamily were retrieved and were manually
aligned using MUST software [22]. The alignment, including small gaps, consisted of 160
amino acids. We removed both the PTP_Pig sequence (gi:3024090) because it was
incomplete, and the INGAP sequence of mouse (gi:7023941), because it is probably a
Reg IIIδ  polymorphic sequence (gi:6633974). The INGAP sequences of hamsters
5(gb:AAB16754.1) and humans (gb:AAB86497.1) proposed by Rafaeloff et al. [23] were
surprisingly identical. Exhaustive searches in databases showed that this latter sequence has
never been identified in any of the genomic databases. We attributed this INGAP sequence to
the hamster. Finally, the Reg-related sequence (RS, gi:893382) was not included because of
its premature ending due to an in-frame stop codon.
2.3. Phylogenetic analysis
Phylogenetic analysis. Phylogenetic analyses were conducted on the amino acid dataset
including 21 taxa (19 Reg sequences and 2 outgroups) for 153 sites, after removal of the
seven first amino acids of Reg II_Mouse. Trees were reconstructed using two different
probabilistic approaches, the maximum likelihood method and the Bayesian inference. In both
cases, we used the empirical substitution matrix between amino acids (JTT substitution
model, [24]), with rate heterogeneity between sites being estimated by a gamma distribution
with four discrete categories and a proportion of invariable sites. The maximum likelihood
approach was performed with the program PhyML [25] for which nodal support was
estimated with 1000 bootstrap replications. The Bayesian tree was constructed with the
MrBayes 3.0b4 program [26] using 4 chains that were run for 1,000,000 generations.
Posterior probabilities were determined from the 50% majority rule consensus of trees
sampled every 50 generations and from burn-in of the first 1,500 trees (stationarity of
likelihood values was checked empirically).
2.4. PCR experiments
PCR tests were done on human Multiple Tissue cDNA (MTC Human I, Clontech Lab.
6Inc., Palo Alto, CA) and on small intestine cDNA synthesized from total RNA (Clontech)
with the recombinant Taq DNA polymerase (Gibco, Invitrogen Corp., Carlsbad, CA)
according to supplier instructions. Primers were designed for specifically amplifying Reg or
PAP genes: REG Iα  5 '  (AGTGTTAATCCTGGCTACTGTGTG) and 3'
( A G A G T G T C C A G G T T G A G T T G A G T T ) ,  R E G  Iβ  5 '
(GTGCTAATGCTGGCTACTGTGCA) and 3' (GGTGAAGGTACTGAAGATCAGCG),
H I P / P A P  5 '  ( G T G G A A A G A T T A T A A C T G T A A T G T G )  a n d  3 '
( C T T T A A A G C C T T A G G C C G T A T G A ) ;  P A P  I B  5 '
(GTGGAAAGATTATAACTGTGATGCA) and 3' (CTCTGAGATCTCAAGACATGGAA).
These primers amplified a 212 bp fragment for REG Iα, a 249 bp fragment for REG Iβ, a
256 bp fragment for HIP/PAP, and a 257 bp fragment for PAP IB. For REG Iα and REG Iβ,
the cycling parameters were the following: initial denaturation 3 min 94°C, 30 sec 94°C, 30
sec 65°C, 1 min 72°C (30-35 cycles), final extension 5 min 72°C. The conditions were
identical for HIP/PAP and PAP Iβ except that annealing was done at 60°C instead of 65°C.
The sequence of each PCR product was checked by DNA sequencing.
2.5. PAP IB subcloning
The PAP clone (ID 2237170) was obtained from the I.M.A.G.E. Consortium (HGMP
Resource Centre, Hinxton, UK). PAP IB cDNA was prepared by PCR using the 5'
(CCAGACAAAGCTTACCAGATC) and 3' (CCCACCTGCCGAATTCCTTG) primers, then
digested by HindIII and EcoRI, and ligated with T4 DNA ligase (Gibco Invitro Corp.) for 1h
at room temperature into the HindIII/EcoRI-digested pcDNA 3.1/V5-His mammalian
expression vector (Invitrogen). This construct generates a fusion of PAP IB with a C-terminal
V5 tag. Then, DH5αTM competent cells (Gibco Invitro Corp.) were transformed and plated
7according to manufacturer instructions. Six positive clones were chosen for transfection
experiments. The PAP IB nucleotide sequence has been submitted to GenBank (accession
number AY428734).
2.6. CHO cell culture and transfection
CHO cell line (ECCAC number 85050302) was cultured in Ham’s F12 medium
supplemented with 10% fetal bovine serum (FBS) (Roche, Basel, Switzerland), penicillin
(100 IU/ml), and streptomycin (100 µg/ml). Cells were transfected with lipofectAMINETM
(Gibco, Invitrogen Corp., CA). Forty-eight hours after transfection, the medium was removed
and supplemented by a concentrated Laemmli sample buffer to reach the final concentration:
62 mM Tris.Cl pH 6.8, 2% SDS, 5% glycerol, and 5% β-2-mercaptoethanol. The samples
were then heated at 100°C for 3 min and subjected to 15% sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE). Proteins were then electrotransferred
overnight to a PVDF sheet (Immobilon P, Millipore, Bedford, MA). Non specific sites were
blocked with 5% non-fat milk powder in 20 mM Tris.Cl pH 7.4, and 50 mM NaCl (TBS)
containing 0.1% Tween 20. The blot was incubated 2h at room temperature with anti-V5
antibody (Gibco Invitrogen Corp.) diluted at 1/1000 in TBS supplemented with 0.1%
Tween 20 and 0.3% non-fat milk powder. The membrane was washed five times with TBS,
0.1% Tween 20 and then incubated 2h at room temperature with antiperoxidase conjugated
goat anti-mouse IgG diluted at 1/20,000 in TBS, 0.1% Tween 20, and 0.3% non-fat milk. The
membrane was washed five times with TBS, 0.1% tween 20. The revelation was done by
chemiluminescence (Pierce, Rockford, IL).
2.7. Molecular modeling
8Homology modeling of the human PAP IB was performed according to the main
principles outlined by Greer [27]. We used the Accelrys software modules InsightII,
Homology, and Discover (San Diego, CA), run on a Silicon Graphics O2 workstation (SGI,
Mountain View, CA). The human PAP IB protein sequence was aligned against the protein
sequences from the PDB (Protein Data Bank) by using the SSEARCH program
(http://pbil.univ-lyon1.fr) and we identified REG Iα/lithostathine (1QDD) as the best
reference to build the PAP IB three-dimensional model. (SCRs) and loops. The main
modeling steps involved first the transfer of coordinates between the "structurally conserved
regions" (SCRs), the building of loops, and the optimization of the side-chain orientations.
Then, the final structural model was refined by energy minimization, using the consistent
valence forcefield (cvff) and the steepest descent and conjugate gradient algorithms, down to
a maximum derivative of 0.01 kcal/Å/mol. The final energy of the resulting model was
–1416 kcal. The validity of the model was assessed by both ‘structural check’ and ‘folding
consistency verification’ using respectively Prostat ([28] and [29]) and Profiles_3D [30]
programs within the Homology module. No spurious angle, bond length, or misfolded region
was detected. The percentage of the so-called ‘most favored regions’ in the Ramachandran
plot was 81% for PAP IB (relatively to 83.8% for the template 1QDD).
3. Results
3.1. A novel Reg-like gene, PAP IB, maps at 2p12
Because all Reg proteins had been localized on chromosome 2 at the 2p12 locus, we
looked at the existence of new genes in this family through the successive genome drafts. By
9analyzing the sequences at locus 2p12, we identified a novel PAP-like sequence that we
named PAP IB according to international rules [31]. The PAP IB_Human nucleotidic
sequence was predicted by assemblies of EST through the CAP software [32]: BF056837,
AI621017, AI027597, AA621263, AA725500, AI025191, AA399061, AW962460,
AW196366, AW002913, AA397543, C17743, AA367364, AI198647. The sequence was then
translated into the three ORF and the longest one was selected. At the same time, Okamoto
group also identified this gene and named it REG III [18].
3.2. Human PAP IB gene cloning and expression
To establish that PAP IB is not only transcribed but also exists as a true protein, we
transfected CHO cells with a PAP IB construct as described in “Material & Methods”.
Figure 1 shows the protein is secreted in the extracellular milieu as expected, and that the size
of the band (15.5 kDa) is in good agreement with the expected theoretical size (16.5 kDa).
3.3. Reg and Reg-related genes display specific sequences and specific structural elements
Members of the Reg multigene family showed a strong similarity with the CTLD domain
found in the calcium-dependent animal lectin superfamily [33] (Fig. 2). This motif includes
four conserved cysteines forming two disulfide bridges (S1 and S2), and additional amino
acids that are structurally essential (“♦” in Fig. 2) [34]. There are, however, four major
differences. First, the Reg multigene family displays an additional disulfide bridge (S3) very
close to the N-terminus. This disulfide bridge directs the separation of Reg proteins into two
parts: a very short N-terminal undecapeptide, except those whose lengths vary (Reg
II_Mouse, REG IV_Human, and Putative_Mouse), and a globular C-terminal domain.
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Second, conversely to true C-type lectins, despite numerous attempts, no carbohydrate ligands
have been identified so far for any Reg protein. Third, in true C-type lectins, the CTLD
contains two calcium-binding sites. Reg proteins do not bind calcium through these sites.
Indeed, site 1 involves an aspartic acid. This acidic residue is systematically lost in Reg
proteins and replaced by aromatic amino acids, most often Y, but also F and H (* in Fig. 2).
In addition, site 1 of true C-type lectins is not topologically equivalent to that of
REG Iα/lithostathine. Therefore, both topology and amino acid substitution prevent calcium
binding ([35], and unpublished observations). Site 2 is topologically conserved through α-
carbon in Reg proteins and C-type lectins such as rat-mannose-binding protein, but this site
displays different amino acids that are expected to prevent calcium binding [35] (not shown).
However, REG Iα/lithostathine binds calcium via a cluster of acidic amino acids located in
the surface of the protein [36]. Fourth, there are several other extremely conserved amino
acids specific to the whole Reg family compared to true C-type lectins (highlighted in Fig. 2).
All in all, these observations showed that Reg proteins formed a distinct subclass of the
family of proteins that contain CTLDs with characteristic features. This alignment of Reg
genes was then used for phylogenetic studies as explained in the next section.
3.4. Hierarchical organization of the Reg genes
To have an exhaustive view of the Reg genes organization, we first built an IBT tree on 774
members of the lectin superfamily from the Pfam alignment. For this purpose, we used the
neighbor-joining algorithm implemented in the MEGA software [Kumar, 1994 #429]. The
results revealed the presence of a monophyletic Reg family containing 19 members found in
mammals only (data not shown). No related genes have been characterized in other eukaryotic
kingdoms such as fungi or plants. On the basis of the IBT tree, we were able to choose two
non-mammal lectin sequences as outgroups, the closest to the Reg family: the BAC54022.1
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eel sequence and the sp P81017 viper sequence. Results of phylogenetic analyses conducted
with the maximum likelihood method and Bayesian inference strongly supported the
existence of three different families called FI, FII and FIII (Fig. 3). FI family included 11
sequences among which the mean percent sequence divergence is 39 ± 10 % (mean ± SD). In
FI, both reconstruction methods provided a strong support for the existence of 5 subgroups (a,
b, c, d, and e in Fig. 3). Among them, subgroups b (Posterior Probabilities = 1, Bootstrap
Proportion = 100), c (PP = 1, BP = 100), d (PP = 1, BP = 99), and e (PP = 1, BP = 100) most
probably arose from four specific duplications in the rodent lineage because corresponding
genes do not exist in the human lineage. By contrast, relationships between the clades b to e
were not well supported, preventing to know in which order these duplications arose. The
human HIP/PAP and PAP IB (16.1 % of divergence, subgroup a, PP = 0.97, BP = 82) are
likely to be paralogous genes. The PTP_bovin gene appeared as the first emergence in the FI
family. Although not supported in the maximum likelihood method, this position is coherent
with molecular studies on mammalian relationships showing that rodent and primates belong
to the same clade (Euarchontoglires ; [Murphy, 2001 #856]). Five Reg sequences were
included in the FII family and the mean percent sequence divergence is 24.4 ± 7.5 % whereas
the mean divergence between FI and FII families is 57.3 ± 2.5 %. An independent human
duplication for the REG I genes was strongly supported (PP=0.9, BP=76). These observations
indicated that an ancestor common to rodent and primate lineages possessed the PAP-like and
REG1-like genes. Finally, the third family (FIII) only included three members:
REG IV_Human, Reg IV_Rat and Putative_Mouse. The mean sequence divergence between
the three sequences was 26.4 % and the mean divergence between FIII and FI, and FIII and
FII was 69.7 ± 2.6 % and 69.8 ± 1.8 %, respectively. In addition, REG IV_Human is localized
on chromosome 1, whereas all other members are located in the same cluster of
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chromosome 2 (Fig. 4). These results are in agreement with human Reg genes hierarchical
organization of obtained by Nata and collaborators [18].
3.5. Human REG I and PAP gene expression
Because REG I and PAP genes belonged to two families, we explored their expression
pattern in a human tissue panel. Unlike the REG Iα gene, expressed in all tested tissues, the
REG Iβ, HIP/PAP, and PAP IB genes were expressed almost only in the pancreas (Fig. 5). A
faint expression of REG Iβ and PAP IB was observed in liver and placenta respectively. In
small intestine, we only observed a clear expression of REG Iα, REG Iβ and HIP/PAP
whereas PAP IB expression was nearly absent (Fig 5E). Differential expression patterns
between HIP/PAP and PAP IB were also reported in small intestine, liver, hepato-carcinoma,
stomach, kidney and testis [18]. First, these results showed that REG Iα gene probably has
pleiotropic roles in the organism; by contrast, the expression of REG Iβ and PAP genes
seemed more restrictive. Second, results suggested that, in spite of recent divergence,
REG Iα_Human and REG Iβ_Human genes, HIP/PAP and PAP IB, might already have
different roles in the organism.
3.6. PAP IB and REG Iα/lithostathine are a structural family within the CTLD domain
superfamily
To correlate likely functional variations with structural differences between PAP IB and
REG  Iα /lithostathine, we compared the three-dimensional structures of the newly
characterized PAP IB (coded by PAP IB_Human gene, FI) and the most representative Reg
protein, REG Iα/lithostathine (coded by REG Iα_Human gene, FII). The known three-
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dimensional structure of REG Iα/lithostathine ([35] and [39]) allowed us to model that of
PAP IB (see the Materials and Methods section). The resulting model is shown in Figure 6A.
The r.m.s.d. value between the PAP IB modeled structure and the REG Iα/lithostathine
crystallographic one was 0.5 Å. The only distinctive topological feature was the 5-residue-
longer PAP IB loop between the β4 and β5 strands (as indicated by a solid arrow pointing to
this blue region). In fact, this loop, which is specific to the lithostathine structural family,
belongs to a larger region that is highly divergent from that of the snake venom lectin-type
toxins (data not shown).
3.7. REG Iα/lithostathine and PAP IB showed a distinctive charge distribution
Interestingly, beyond their similar fold, REG Iα/lithostathine and PAP IB differ in the
density distribution of their charged residues (Fig. 6B-D). This is especially visible at the
level of the differential loop, which is negatively charged for PAP IB whereas it is positively
charged for REG Iα/lithostathine (Fig. 6C-D). In addition, other regions also differ in charge
throughout the whole sequence. Interestingly, HIP/PAP, which also belongs to the FIa sub-
family like PAP IB (see Fig. 3), displays the same structural characteristics as PAP IB (Fig.
6B). This peculiarity may have important consequences in terms of function. All in all, these
results underline that, in spite of the same general fold, REG Iα/lithostathine and PAP IB may
differ in their function via local structural differences.
4. Discussion
Here we described a new member of the Reg family, named PAP IB, located on
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chromosome 2. PAP IB is in the same cluster as other Reg genes, suggesting that this
multigene family probably arose by gene duplication (see below). The Reg family is specific
to mammals, and phylogenetic analysis of 18 mammalian sequences revealed the existence of
different species-specific paralogous genes clustering in three families. Not only are these
families of unequal size but also their diversification differs with the lineage. In the PAP
family (FI), phylogenetic relationships in rodents indicate that duplication occurred at least 4
times (subgroups b to e) but only once in the human lineage. At the present time, however, it
is not possible to know which genes are orthologous in the two lineages.
The Reg family possibly evolved through duplication events that have conferred a direct
advantage to the organism (positive selection) or by recurrent duplications that have led to a
polymorphism with chromosomes carrying different copy numbers [40]. This notion is largely
corroborated by our detailed structural analysis of REG Iα/lithostathine and PAP IB, which
belong to two main distinct branches of the phylogenetic tree (FI and FII, respectively).
Indeed, human REG Iα/lithostathine and PAP IB belong to a single structural clade based on
the remarkable conservation of the types of residues that govern folding (i.e. the
hydrophobic/aromatic residues and the Cys, Pro, and Gly residues). This similar fold is
clearly distinct from those formed by other members of the CTLD superfamily, as shown by
our structural alignments (unpublished results). The similar fold might therefore reflect a
general function common to Reg proteins, such as interactions with similar protein partners or
involvement in similar signalization pathways. For example, REG Iα/lithostathine and
HIP/PAP (the closest relative to PAP IB according to our phylogenetic tree) are both
inflammatory proteins overexpressed in the brain of patients with Alzheimer’s disease [13].
In the course of evolution, duplicate genes have many fates: they can conserve the same
functions, be lost, evolve to pseudogenes, or generate highly different functions [41].
Therefore, linking genome sequence analysis to protein structure, and then to function, is the
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major endeavor of the post-genomic era (for reviews, see [42], [43] and [44]). Here, the
structure of the newly described PAP IB protein was predicted through comparative
modeling. Taking into account both the 50% sequence identity between the two sequences
and the high-resolution crystallographic structure of REG Iα/lithostathine, we were in the
requested conditions to accurately build a homology-derived model of PAP IB. That the
PAP IB modeled backbone differed from the one of REG Iα/lithostathine by only 0.5 Å
highlights the inherent topological similarity between the two proteins. According to Wilson
et al. [45], proteins/domains with a common fold and sequence identities down to about 40%
have the same specific function, whereas between 40% and 25%, they share only the “broad”
function. This stands true in the case of the RRM (RNA Recognition Motif) domains: as a
whole family of about 200 members, they share only 24% sequence identity (according to
Pfam database) for a common single-stranded RNA recognition activity, but, as a specific
sub-class of AU-rich RNA binders, they possess 37% sequence identity [46]. In fact, the 40%
threshold is only a “rule of thumb”, subject to variations depending on the domain family.
Thus, the 50% sequence identity level between PAP IB and REG Iα/lithostathine is enough to
direct the general Reg-type fold, but it may not be sufficient to ensure the same specific
function to the two proteins. As suggested by Andrade and colleagues [47], if the overall fold
is responsible for invariable aspects of function, more subtle properties would be responsible
for the divergent aspects of function. This observation raises a major question: Are there other
specific functions that could be related to structural properties other than the overall fold ?
One potential source of functional diversity could be the charge of the protein. As first
defined by Lichtarge et al. [48], the powerful concept of evolutionary trace has revealed that
surface map comparison can rationalize the functional variation within a divergent group of
proteins ([49], [50] and [51]). Indeed, besides their different tissue expression, PAP IB and
REG Iα/lithostathine display notable different structural properties at a finer level. For
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instance, the specific loop of Reg protein family, between β4 and β5, is both 5 residues longer
and oppositely charged in PAP IB relative to REG Iα/lithostathine. The different charge
distributions of PAP IB and REG Iα/lithostathine that we observed might generate specific
responses to different ligands that need to be further investigated.
Our results confirm that the complexity of organisms is not linked to the number of
genes, but rather to the ability of an organism to duplicate, diverge and recombine, thus
creating new functions. This work illustrates that the marriage of phylogeny systematics with
structural studies promises new insights into the nature of biological structure/function
relationships. Both the genome organization and the three-dimensional structure of proteins
should be part of the study of evolution.
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Figure legends
Figure 1. Immunodetection of PAP IB after CHO transfection. Lane M: Molecular weight
markers. Lane C: Control experiment after transfection with pcDNA 3.1/V5-His vector.
Lane PAP IB: Extracellular milieu after transfection with PAP IB construct. The sample was
analyzed on immunoblots with anti-V5 antibody which recognizes the C-terminal V5 tag of
PAP IB. Molecular weight standards are given by ChemiBlot Molecular Weight Markers-
Trial from Chemicon international, Inc (Temecula, California).
Figure 2. Sequence alignment of the Reg family proteins. All members of the Reg family are
secretory proteins. Signal peptide cleavage sites were predicted according to Nielsen et al.
[52], except for REG Iα/lithostathine_Human biochemically determined [53]. Residues are
indicated by a single-letter amino acid code. Sequence gaps introduced to optimize the
alignment are indicated by dashes. The box corresponds to the CTLD domain [33]. The
invariant amino acids in C-type lectin [34] are indicated by a black diamond-shaped ("♦").
"+" signs refer to the residues involved in the two calcium binding sites of C-type lectins.
Gray highlighted amino acids represent residues strictly conserved throughout the whole Reg
family. The star sign (*) indicates the mutation in Reg proteins preventing calcium binding.
S1, S2, and S3 represent the three disulfide bridges. See also the paper by Okamoto and
Takasawa [54].
Figure 3. Phylogram of the REG family members obtained with the Bayesian approach. The
eel and viper sequences were used as outgroups. The JTT substitution model was used with
rate heterogeneity between sites estimated by a gamma distribution and a proportion of
invariable sites. Numbers at nodes refer, from left to right, to Bayesian posterior probabilities
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and bootstrap proportions in Maximum Likelihood. FI, FII and FIII represent the three
families with regard to the human sequences. Clades a-e represent the five subgroups
observed in FI family.
Figure 4. Chromosomal organization of human Reg genes. Arrows indicate the sense of
translation. ATG start (upper) and STOP (lower) codon numbers are indicated for each gene.
Number 1 was attributed to the ATG of HIP/PAP. Φ is a Reg related pseudogene.
Figure 5. Comparison of tissue expression pattern of REG and PAP mRNAs in the sample
MTC panel. The expressions of Reg and PAP genes were analyzed by RT-PCR with specific
primers. After amplification cycles, samples were electrophoresed on 2.5% agarose/EtBr gels:
lane 1 (heart), lane 2 (brain), lane 3 (placenta), lane 4 (lung), lane 5 (liver), lane 6 (skeletal
muscle), lane 7 (kidney), lane 8 (pancreas), and lane 9 (control experiment). Panel A:
REG Iα; panel B: REG Iβ; panel C: HIP/PAP; panel D: PAP IB. Panel E : expression in small
intestine of REG Iα  (lane 10), REG Iβ  (lane 11), HIP/PAP (lane 12), PAP IB (lane 13).
Molecular weight standards (M) are given by X174 RF DNA/HaeIII from Invitrogen Corp.
Control experiments showed no detectable bands.
Figure 6. Structural analysis (A) Model of the three-dimensional structure of the human
PAP IB built by homology with REG Iα/lithostathine. The 10 structurally conserved elements
‘β1β2α1β3α2β4β5β6β7β8’ are numbered sequentially and are color-coded (α-helices in brown
and β-strands in indigo). The blue arrow points to the distinctive feature, the longer loop
between β4 and β5 than in REG Iα /lithostathine. The five-residue insertion QGSEP,
characteristic of PAP IB, is in blue. (B) Multiple-sequence alignment of PAP IB, HIP/PAP
and REG Iα/lithostathine showing the respective distributions of acidic residues in brown and
19
basic residues in turquoise (C, D) Charged residue distribution at the surface of human
PAP IB and REG Iα/lithostathine. Acidic and basic residues are displayed in Connolly
surface mode and color-coded as in B. The brown and green arrows point to the differential
loop, respectively 5 residues longer and negatively charged in PAP IB and short and
positively charged in REG Iα/lithostathine.
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